In plain words

Small studies gave people NMN for weeks to months and tested grip, leg or chair-stand strength. Most found no difference from people taking a placebo or only exercising. One trial in healthy older men found a partial gain in grip.

The short answer

Two of the three randomized trials found no difference: Kim (2022) in 108 people at 250 mg a day for 12 weeks, and Liao (2021) in 48 exercisers at 300 to 1,200 mg a day for 6 weeks. Igarashi (2022) found partly better grip in older men at 250 mg a day for 12 weeks; the ledger has no n. A 24-week placebo comparison in 14 people at 250 mg a day found no difference. A review describes a 4-week trial of 2,000 mg a day in 30 people with no gain in maximum strength. Certainty is low, because the studies are small and short.

The 60-second version

Every study in the video is listed below, with its quote.

Watch on YouTube

Where the evidence sits

Strength improved

■ Randomized trial, Igarashi et al., 2022 · ledger has no n

No difference

■ Randomized trial, Kim et al., 2022 · 108 people · 12 weeks · chair stands rose in all groups
■ Randomized trial, Liao et al., 2021 · 48 people · 6 weeks
■ Cohort study, Akasaka et al., 2022 · 14 people · 24 weeks
◪ Pooled analysis, Prokopidis et al., 2025 · may overlap studies counted here
□ Review, Prokopidis et al., 2025 · summarises other studies · placebo did more leg reps
□ Review, Wen et al., 2024 · summarises other studies
□ Review, The Conversation, 2026 · summarises other studies

■ measured by the source's own study · ◪ pooled analysis, may overlap studies counted here · □ reported, reviewed or argued, no new data

Evidence weight5454 / 100?

Who says what

SourceFindingDesignPeopleDose and lengthFunding and independence
Igarashi et al., 2022Grip partly betterRandomized trialOlder men, n not in ledger250 mg/day, 12 weeksNot in ledger
Kim et al., 2022No grip changeRandomized trial with placebo groups108250 mg/day, 12 weeksNot in ledger
Liao et al., 2021No gain over exercise aloneRandomized trial48300 to 1,200 mg/day, 6 weeksNot in ledger
Akasaka et al., 2022No grip differenceNMN versus placebo study14250 mg/day, 24 weeksNot in ledger
Prokopidis et al., 2025No pooled grip differenceMeta-analysis, may include trials aboveNot in ledgerNot in ledgerNot in ledger
Wen et al., 2024Nonsignificant improvementReview, may include trials above437150 to 1,200 mg/day, 4 to 12 weeksNot in ledger
The Conversation, 2026No convincing evidenceArticle summarising reviewsNoneNoneKingston University authors
Igarashi et al., 2022

Grip partly better

Design
Randomized trial
People
Older men, n not in ledger
Dose and length
250 mg/day, 12 weeks
Funding
Not in ledger
Kim et al., 2022

No grip change

Design
Randomized trial with placebo groups
People
108
Dose and length
250 mg/day, 12 weeks
Funding
Not in ledger
Liao et al., 2021

No gain over exercise alone

Design
Randomized trial
People
48
Dose and length
300 to 1,200 mg/day, 6 weeks
Funding
Not in ledger
Akasaka et al., 2022

No grip difference

Design
NMN versus placebo study
People
14
Dose and length
250 mg/day, 24 weeks
Funding
Not in ledger
Prokopidis et al., 2025

No pooled grip difference

Design
Meta-analysis, may include trials above
People
Not in ledger
Dose and length
Not in ledger
Funding
Not in ledger
Wen et al., 2024

Nonsignificant improvement

Design
Review, may include trials above
People
437
Dose and length
150 to 1,200 mg/day, 4 to 12 weeks
Funding
Not in ledger
The Conversation, 2026

No convincing evidence

Design
Article summarising reviews
People
None
Dose and length
None
Funding
Kingston University authors

Which trial found a gain?

Igarashi (2022) gave healthy older men 250 mg of NMN a day for 12 weeks and reported better left-hand grip; the ledger has no n for the trial:

These findings indicate that the chronic oral supplementation of NMN partly improved the muscle strength and performance in healthy older men, although NMN did not affect the skeletal muscle mass.

Did other studies find the same?

Kim (2022) gave 108 people 250 mg a day for 12 weeks: grip did not change significantly, and on five chair stands the afternoon NMN group had the largest before-after effect (d = 0.72), though all four groups improved, placebo included:

The post hoc analysis revealed significantly improved 5-STS in Post compared with Pre in all groups.

Liao (2021) found no difference in grip, push-ups or sit-and-reach when 48 exercisers added 300, 600 or 1,200 mg a day for 6 weeks. Akasaka (2022) found grip no different between NMN and placebo in 14 people at 250 mg a day for 24 weeks.

What do the reviews add?

Prokopidis (2025) describes a trial of 30 people at 2,000 mg a day for 4 weeks with no change in chest press or leg press maximum, and one difference:

a statistical change on leg press to failure was demonstrated, for which, the placebo group performed more repetitions (p = 0.02)

Prokopidis also pooled grip data and found no difference, a pooled estimate that may include the trials above. Wen (2024), reviewing 10 trials in 437 people (150 to 1,200 mg a day, 4 to 12 weeks) that may include the trials above, found NMN was associated with a nonsignificant improvement in strength.

Why the sources disagree

Dose ran from 250 to 2,000 mg a day and length from 4 to 24 weeks, in healthy older men, exercisers and other adults, tested by grip, chair stands or presses. Igarashi's gain was in the left hand. Kim's chair-stand rise appeared in the placebo groups too, so change from baseline and difference from placebo can point different ways. The ledger has no funding details for any study.

What would settle it

An independent randomized trial of 250 mg and 1,000 mg of NMN a day against placebo for 24 weeks in at least 200 older adults, with grip in both hands and leg press as pre-registered outcomes. A matching result from a second research group would raise certainty from low to moderate.

How this page was made

The 7 sources are four studies that measured strength themselves, two systematic reviews (Prokopidis, with a meta-analysis giving a pooled estimate that may include the trials above, and Wen) and an article in The Conversation, found by a literature search. Every claim was copied word for word into the Longevity Circle ledger and checked against the original text, and a person approved each one. Certainty follows the GRADE levels used in medical reviews. Drafting was assisted by AI.

Changelog: 23 Sep 2026, first version, 7 sources.